The Zepp Clarity Omni is a budget-priced OTC hearing aid released in 2024, earning a D grade in HearAdvisor's lab testing. At $399, it sits in the lowest price tier of the OTC category, but our testing revealed significant performance concerns that place it near the bottom of devices we've evaluated.
In our standardized lab protocol, the Omni ranked #51 out of 56 OTC hearing aids tested, with a SoundScore of 1.11 out of 5—well below the category average of 3.43. This represents a substantial gap compared to similarly-priced alternatives. For context, the Elehear Beyond achieves a score of 4.35 at the same $399 price point, while several other budget options like the JLab Hear OTC (3.65) and Apple AirPods Pro 2 (3.56) significantly outperform the Omni.
The device does offer modern convenience features including rechargeable batteries, iPhone and Android streaming capability, and hands-free functionality in a behind-the-ear form factor. However, these features don't compensate for the core sound performance limitations we measured.
Based on our testing, consumers in the budget OTC segment have considerably stronger options available at this price point. Those prioritizing sound quality for speech understanding should explore higher-performing alternatives before considering the Zepp Clarity Omni.
